Advisor Group Holdings, Inc. Blueprint Medicines Corp Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,652 shares of BPMC stock, worth $210,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,652
Previous 5,041 67.23%
Holding current value
$210,795
Previous $439,000 66.74%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$86.69 - $115.63 $293,792 - $391,870
-3,389 Reduced 67.23%
1,652 $146,000
Q4 2024

Feb 07, 2025
BUY
$82.48 - $101.39 $56,003 - $68,843
679 Added 15.57%
5,041 $439,000
Q3 2024

Nov 13, 2024
SELL
$84.1 - $120.5 $608,127 - $871,335
-7,231 Reduced 62.37%
4,362 $403,000
Q2 2024

Aug 13, 2024
BUY
$85.18 - $108.78 $942,005 - $1.2 Million
11,059 Added 2070.97%
11,593 $1.25 Million
Q1 2024

May 10, 2024
SELL
$73.17 - $99.79 $557,774 - $760,699
-7,623 Reduced 93.45%
534 $50,000
Q4 2023

Feb 12, 2024
BUY
$43.96 - $92.84 $239,274 - $505,328
5,443 Added 200.55%
8,157 $752,000
Q3 2023

Nov 13, 2023
BUY
$46.9 - $66.0 $4,127 - $5,808
88 Added 3.35%
2,714 $136,000
Q2 2023

Aug 10, 2023
BUY
$42.2 - $66.37 $5,528 - $8,694
131 Added 5.25%
2,626 $165,000
Q1 2023

May 12, 2023
SELL
$37.97 - $50.0 $33,375 - $43,950
-879 Reduced 26.05%
2,495 $112,000
Q4 2022

Feb 10, 2023
SELL
$41.06 - $66.48 $6,282 - $10,171
-153 Reduced 4.34%
3,374 $147,000
Q3 2022

Nov 14, 2022
SELL
$49.93 - $77.7 $9,237 - $14,374
-185 Reduced 4.98%
3,527 $233,000
Q2 2022

Aug 10, 2022
BUY
$45.23 - $70.15 $31,118 - $48,263
688 Added 22.75%
3,712 $188,000
Q1 2022

May 04, 2022
SELL
$54.1 - $110.08 $25,643 - $52,177
-474 Reduced 13.55%
3,024 $193,000
Q3 2021

Nov 05, 2021
BUY
$80.98 - $109.47 $2,186 - $2,955
27 Added 0.78%
3,498 $360,000
Q2 2021

Aug 02, 2021
BUY
$82.78 - $101.0 $81,786 - $99,788
988 Added 39.79%
3,471 $303,000
Q1 2021

May 13, 2021
BUY
$90.71 - $108.28 $22,042 - $26,312
243 Added 10.85%
2,483 $242,000
Q4 2020

Feb 10, 2021
BUY
$92.08 - $124.48 $13,443 - $18,174
146 Added 6.97%
2,240 $252,000
Q3 2020

Nov 12, 2020
BUY
$66.45 - $92.7 $8,040 - $11,216
121 Added 6.13%
2,094 $193,000
Q2 2020

Aug 14, 2020
BUY
$57.09 - $79.27 $81,638 - $113,356
1,430 Added 263.35%
1,973 $154,000
Q1 2020

May 18, 2020
BUY
$48.11 - $82.22 $26,123 - $44,645
543 New
543 $32,000

Others Institutions Holding BPMC

# of Institutions
391
Shares Held
68.5M
Call Options Held
1.54M
Put Options Held
1.08M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email